Regions/Cells | Normal Carrageenan (CA) | CA + Dexamethasone | CA + PS + CR 0.3 (g/kg) | CA + PS + CR 1.0 (g/kg) | |
---|---|---|---|---|---|
Dorsum pedis skin | |||||
 Epidermis (cells/100 epithelial cells) |  |  |  |  | |
  COX-2 + cells | 3.60 ± 2.61 | 77.60 ± 5.94d | 27.80 ± 10.57de | 59.60 ± 9.71df | 36.00 ± 6.52de |
  iNOS + cells | 4.40 ± 2.30 | 86.80 ± 5.81a | 35.00 ± 7.52ac | 73.80 ± 4.32ac | 56.40 ± 8.41ac |
  TNF-α + cells | 1.00 ± 0.71 | 87.20 ± 6.06a | 11.40 ± 4.10bc | 70.80 ± 7.46ac | 41.40 ± 7.40ac |
 Dermis (cells/mm2 of dermis) |  |  |  |  | |
  Mast cells | 90.40 ± 15.63 | 22.00 ± 7.52a | 74.20 ± 4.44bc | 48.00 ± 13.36ac | 64.20 ± 13.59ac |
  COX-2 + cells | 13.20 ± 6.57 | 160.00 ± 31.34d | 38.80 ± 10.55de | 103.80 ± 9.86de | 56.20 ± 18.39de |
  iNOS + cells | 18.60 ± 2.41 | 379.60 ± 81.04d | 78.80 ± 12.13de | 216.40 ± 71.14df | 109.00 ± 54.16de |
  TNF-α + cells | 10.20 ± 1.92 | 175.80 ± 21.31a | 47.60 ± 12.93ac | 112.20 ± 25.41ac | 72.20 ± 17.67ac |
Ventrum pedis skin | |||||
 Epidermis (cells/100 epithelial cells) |  |  |  |  | |
  COX-2 + cells | 3.80 ± 1.70 | 67.40 ± 4.51a | 24.00 ± 7.91ac | 53.00 ± 7.18ac | 39.40 ± 4.67ac |
  iNOS + cells | 13.40 ± 3.58 | 63.00 ± 6.52a | 23.40 ± 6.19bc | 47.40 ± 6.58ac | 35.40 ± 5.13ac |
  TNF-α + cells | 5.20 ± 2.39 | 82.00 ± 10.89a | 33.00 ± 11.58ac | 56.40 ± 6.23ac | 40.40 ± 12.60ac |
 Dermis (cells/mm2 of dermis) |  |  |  |  | |
  Mast cells | 81.60 ± 10.90 | 7.20 ± 3.35a | 57.80 ± 8.01ac | 29.20 ± 7.19ac | 49.00 ± 10.72ac |
  COX-2 + cells | 33.40 ± 11.61 | 823.00 ± 104.48a | 146.20 ± 88.37bc | 476.40 ± 98.22ac | 309.40 ± 79.63ac |
  iNOS + cells | 27.60 ± 10.62 | 727.00 ± 102.27a | 145.80 ± 50.93bc | 485.00 ± 88.26ac | 338.00 ± 54.35ac |
  TNF-α + cells | 19.20 ± 4.60 | 794.20 ± 110.87d | 57.20 ± 17.48de | 308.00 ± 56.57de | 144.00 ± 40.35de |